Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis

Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.

. 2005 ; 15 (6) : 369-376.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07520181

Grantová podpora
NB7099 MZ0 CEP - Centrální evidence projektů

Ghrelin was originally isolated from the rat stomach and significant amounts were found also in the kidney. Present study was designed to examine changes in ghrelin levels in renal failure and their relationship to the GH/IGF-I axis. Fourty patients with mild-to-severe CRF (19 men, 21 women, aged 62.5 +/- 2.2 years, BMI 27.57 +/- 0.73 kg/m(2)) and 34 healthy control subjects (17 men, 17 women, aged 60 +/- 2.6 years, BMI 27.55 +/- 0.79 kg/m(2)) were included in the study. Total ghrelin levels were significantly increased in patients with chronic renal failure (CRF) (p < 0.0001). Total ghrelin in CRF correlated positively with active ghrelin (p < 0.001), GH (p < 0.05), IGF-I (p < 0.05), free IGF-I (p = 0.0001), IGFBP-3 (p < 0.01), IGFBP-2 and -6 (p < 0.05). Active ghrelin in CRF correlated positively with IGF-I (p < 0.001), free-IGF-I (p < 0.005), IGFBP-2 (p < 0.05) and IGFBP-3 (p < 0.05). However, most of the correlation were markedly reduced and the significance disappeared after adjustment for different creatinine levels. Hemodialysis in patients with end stage renal disease (ESRD) resulted in a significant reduction of plasma total and active ghrelin (p < 0.01 and p < 0.001 respectively). In conclusion we demonstrated elevated plasma levels of total ghrelin in CRF, and a reduction of total and active ghrelin after a single course of hemodialysis in ESRD. The elevation of ghrelin levels could be caused by impaired clearance and/or metabolism of ghrelin in the kidney. We did not prove clearly significant relationship between ghrelin serum levels and parameters of GH/IGF-I axis in study subjects.

000      
00000naa 2200000 a 4500
001      
bmc07520181
003      
CZ-PrNML
005      
20130225090354.0
008      
090327s2005 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jarkovská, Zuzana $7 xx0056683
245    10
$a Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis / $c Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.
314    __
$a Third Department of Medicine, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08 Prague 2, Czech Republic
520    9_
$a Ghrelin was originally isolated from the rat stomach and significant amounts were found also in the kidney. Present study was designed to examine changes in ghrelin levels in renal failure and their relationship to the GH/IGF-I axis. Fourty patients with mild-to-severe CRF (19 men, 21 women, aged 62.5 +/- 2.2 years, BMI 27.57 +/- 0.73 kg/m(2)) and 34 healthy control subjects (17 men, 17 women, aged 60 +/- 2.6 years, BMI 27.55 +/- 0.79 kg/m(2)) were included in the study. Total ghrelin levels were significantly increased in patients with chronic renal failure (CRF) (p < 0.0001). Total ghrelin in CRF correlated positively with active ghrelin (p < 0.001), GH (p < 0.05), IGF-I (p < 0.05), free IGF-I (p = 0.0001), IGFBP-3 (p < 0.01), IGFBP-2 and -6 (p < 0.05). Active ghrelin in CRF correlated positively with IGF-I (p < 0.001), free-IGF-I (p < 0.005), IGFBP-2 (p < 0.05) and IGFBP-3 (p < 0.05). However, most of the correlation were markedly reduced and the significance disappeared after adjustment for different creatinine levels. Hemodialysis in patients with end stage renal disease (ESRD) resulted in a significant reduction of plasma total and active ghrelin (p < 0.01 and p < 0.001 respectively). In conclusion we demonstrated elevated plasma levels of total ghrelin in CRF, and a reduction of total and active ghrelin after a single course of hemodialysis in ESRD. The elevation of ghrelin levels could be caused by impaired clearance and/or metabolism of ghrelin in the kidney. We did not prove clearly significant relationship between ghrelin serum levels and parameters of GH/IGF-I axis in study subjects.
650    _2
$a zvířata $7 D000818
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kreatin $x krev $7 D003401
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ghrelin $7 D054439
650    _2
$a růstový hormon $x metabolismus $7 D013006
650    _2
$a lidé $7 D006801
650    _2
$a protein 2 vázající insulinu podobné růstové faktory $x metabolismus $7 D018971
650    _2
$a IGFBP-3 $x metabolismus $7 D018972
650    _2
$a insulinu podobný růstový faktor I $x metabolismus $7 D007334
650    _2
$a ledviny $x metabolismus $7 D007668
650    _2
$a renální insuficience $x krev $7 D051437
650    _2
$a chronické selhání ledvin $x krev $x metabolismus $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a statistické modely $7 D015233
650    _2
$a peptidové hormony $x chemie $x krev $x metabolismus $7 D036361
650    _2
$a receptory buněčného povrchu $x chemie $7 D011956
650    _2
$a leptinové receptory $7 D054411
650    _2
$a dialýza ledvin $7 D006435
650    _2
$a časové faktory $7 D013997
650    _2
$a financování organizované $7 D005381
700    1_
$a Hodková, Magdaléna. $7 _AN030523
700    1_
$a Sazamová, Magda $7 xx0128462
700    1_
$a Rosická, Martina $7 xx0061797
700    1_
$a Sulková, Sylvie, $d 1954- $7 jn20000710614
700    1_
$a Marek, Josef, $d 1936-2019 $7 nlk19990073526
700    1_
$a Justová, Vlasta $7 xx0099628
700    1_
$a Lacinová, Zdeňka $7 xx0062138
700    1_
$a Haluzík, Martin, $d 1970- $7 xx0000707
700    1_
$a Haas, Tomáš $7 xx0047240
700    1_
$a Kršek, Michal $7 xx0046428
773    0_
$w MED00005163 $t Growth hormone & IGF research $g Roč. 15, č. 6 (2005), s. 369-376 $x 1096-6374
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20130225090552 $b ABA008
999    __
$a ok $b bmc $g 637985 $s 490782
BAS    __
$a 3
BMC    __
$a 2005 $b 15 $c 6 $d 369-376 $i 1096-6374 $m Growth hormone & IGF research $x MED00005163
GRA    __
$a NB7099 $p MZ0
LZP    __
$a 2009-B2/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...